Purpose
To advance the development and evaluation of continuous lyophilization technology for RNA vaccine manufacturing with the goal of improving accessibility of RNA-based vaccines for populations in low- and middle-income countries.
Grantee
Division
Global Health
Date
OCTOBER 2026
Region served
GLOBAL
Committed amount
$318,927
Grant topic
Vaccine Development
Duration (months)
5
Grantee location
Ghent, Belgium
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.